ANORO ELLIPTA inhaler

ANORO ELLIPTA is a prescription inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It combines two bronchodilators: umeclidinium bromide (62.5 mcg), a long-acting muscarinic antagonist (LAMA), and vilanterol (25 mcg), a long-acting beta₂-adrenergic agonist (LABA). These medications work together to relax the muscles around the airways, improving airflow and making breathing easier for individuals with COPD. The inhaler is designed for once-daily use, with each inhalation delivering a fixed dose of both medications. ANORO ELLIPTA is manufactured in multiple countries, with GlaxoSmithKline (GSK) being the ultimate owner of the brand. GSK is a British multinational pharmaceutical company headquartered in Brentford, England, and is one of the world's largest pharmaceutical companies, focusing on developing and manufacturing a wide range of medicines, vaccines, and consumer healthcare products.